BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21427387)

  • 1. Serum and bronchoalveolar lavage fluid galactomannan assays in patients with pulmonary aspergilloma.
    Park SY; Lee SO; Choi SH; Jeong JY; Sung H; Kim MN; Choi CM; Hong SB; Oh YM; Shim TS; Lim CM; Koh Y; Kim DS; Kim YS; Woo JH; Kim SH
    Clin Infect Dis; 2011 Apr; 52(7):e149-52. PubMed ID: 21427387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis.
    Izumikawa K; Yamamoto Y; Mihara T; Takazono T; Morinaga Y; Kurihara S; Nakamura S; Imamura Y; Miyazaki T; Nishino T; Tsukamoto M; Kakeya H; Yanagihara K; Mine M; Yasuoka A; Tashiro T; Kohno S
    Med Mycol; 2012 Nov; 50(8):811-7. PubMed ID: 22568603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
    Danpornprasert P; Foongladda S; Tscheikuna J
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchoalveolar lavage fluid galactomannan detection for diagnosis of invasive pulmonary aspergillosis in chronic obstructive pulmonary disease.
    Zhang XB; Chen GP; Lin QC; Lin X; Zhang HY; Wang JH
    Med Mycol; 2013 Oct; 51(7):688-95. PubMed ID: 23527739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of Serum and Bronchoalveolar Lavage Fluid Galactomannan in Diagnosis of Chronic Pulmonary Aspergillosis.
    Sehgal IS; Dhooria S; Choudhary H; Aggarwal AN; Garg M; Chakrabarti A; Agarwal R
    J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30626661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients.
    Luong ML; Clancy CJ; Vadnerkar A; Kwak EJ; Silveira FP; Wissel MC; Grantham KJ; Shields RK; Crespo M; Pilewski J; Toyoda Y; Kleiboeker SB; Pakstis D; Reddy SK; Walsh TJ; Nguyen MH
    Clin Infect Dis; 2011 May; 52(10):1218-26. PubMed ID: 21507918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples.
    Reinwald M; Spiess B; Heinz WJ; Vehreschild JJ; Lass-Flörl C; Kiehl M; Schultheis B; Krause SW; Wolf HH; Bertz H; Maschmeyer G; Hofmann WK; Buchheidt D
    Eur J Haematol; 2012 Aug; 89(2):120-7. PubMed ID: 22650156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of galactomannan antigen in the bronchial washing and serum for diagnosing pulmonary aspergillosis.
    Kono Y; Tsushima K; Yamaguchi K; Kurita N; Soeda S; Fujiwara A; Sugiyama S; Togashi Y; Kasagi S; To M; To Y; Setoguchi Y
    Respir Med; 2013 Jul; 107(7):1094-100. PubMed ID: 23632100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of detecting bronchoalveolar lavage fluid Aspergillus galactomannan antigen in the diagnosis of pulmonary aspergillosis].
    Hu H; Yang Y; Teng GL; Ju YF; Zhang LL; Wei M
    Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(32):2268-70. PubMed ID: 23158487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis.
    Zhou W; Li H; Zhang Y; Huang M; He Q; Li P; Zhang F; Shi Y; Su X
    J Clin Microbiol; 2017 Jul; 55(7):2153-2161. PubMed ID: 28446576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False positive bronchoalveolar lavage galactomannan: Effect of host and cut-off value.
    Farmakiotis D; Le A; Weiss Z; Ismail N; Kubiak DW; Koo S
    Mycoses; 2019 Mar; 62(3):204-213. PubMed ID: 30387195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of bronchoalveolar lavage galactomannan in the diagnosis of pediatric invasive aspergillosis.
    Desai R; Ross LA; Hoffman JA
    Pediatr Infect Dis J; 2009 Apr; 28(4):283-6. PubMed ID: 19238113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid.
    Pasqualotto AC; Xavier MO; Sánchez LB; de Oliveira Costa CD; Schio SM; Camargo SM; Camargo JJ; Sukiennik TC; Severo LC
    Transplantation; 2010 Aug; 90(3):306-11. PubMed ID: 20548265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance.
    Racil Z; Kocmanova I; Toskova M; Buresova L; Weinbergerova B; Lengerova M; Rolencova M; Winterova J; Hrncirova K; Volfova P; Skrickova J; Mayer J
    Int J Infect Dis; 2011 Dec; 15(12):e874-81. PubMed ID: 22040924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of galactomannan antigen detection in bronchoalveolar lavage fluid in immunocompromised patients.
    Brownback KR; Pitts LR; Simpson SQ
    Mycoses; 2013 Sep; 56(5):552-8. PubMed ID: 23496321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Real-Time PCR and Platelia Galactomannan Assay for the Diagnosis of Invasive Pulmonary Aspergillosis: Bronchoalveolar Lavage Fluid Performs Better Than Serum in Non-neutropaenic Patients.
    Zhang S; Wang S; Wan Z; Que C; Li R; Yu J
    Mycopathologia; 2016 Oct; 181(9-10):625-9. PubMed ID: 27270570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of Galactomannan in Bronchoalveolar Lavage Fluid for Chronic Respiratory Disease with Pulmonary Aspergillosis.
    Lai G; Zeng C; Mo J; Song WD; Xu P
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31941687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases.
    Maertens J; Maertens V; Theunissen K; Meersseman W; Meersseman P; Meers S; Verbeken E; Verhoef G; Van Eldere J; Lagrou K
    Clin Infect Dis; 2009 Dec; 49(11):1688-93. PubMed ID: 19886801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies.
    Luong ML; Filion C; Labbé AC; Roy J; Pépin J; Cadrin-Tourigny J; Carignan S; Sheppard DC; Laverdière M
    Diagn Microbiol Infect Dis; 2010 Oct; 68(2):132-9. PubMed ID: 20846585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts.
    Nguyen MH; Jaber R; Leather HL; Wingard JR; Staley B; Wheat LJ; Cline CL; Baz M; Rand KH; Clancy CJ
    J Clin Microbiol; 2007 Sep; 45(9):2787-92. PubMed ID: 17596367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.